RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...

Children’s Hospital of Erlanger is now accepting appointments to receive the Beyfortus respiratory syncytial virus (RSV) vaccine through Children’s General Pediatrics located at the Kennedy Outpatient ...

In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The mortality risk within 90 days of hospitalization is similar and higher among older adults hospitalized with respiratory syncytial virus (RSV) vs influenza A and those hospitalized with RSV vs ...

pneumococcal pneumonia and respiratory syncytial virus (RSV) infections. State health officials are urging people to protect themselves and their families from respiratory illness, stay up to date on ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.